Table 1

Summary of findings for all primary and secondary outcomes

StudyMortalityMI, n (%)Stroke, n (%)AKI, n (%)Bleeding, n (%)Transfusion, n (%)ICU LOS (hour), mean (SD)Hospital LOS (day), mean (SD)
NIRSControlNIRSControlNIRSControlNIRSControlNIRSControlNIRSControlNIRSControlNIRSControl
Rogers et al 36 1 (1)2 (1.88)1 (1)2 (1.88)1 (1)02 (2)5 (4.71)6 (6.1)4 (3.77)37 (37.7)44 (45.8)3.3 (0.81)3.67 (0.79)7.5 (1.15)8 (1.17)
Deschamps et al 29 4 (11.7)6 (13)001 (2.9)2 (4.3)12 (35.2)17 (47.2)2.99 (2.26)0.39 (2.05)11 (7.2)9.9 (5.8)
Kara et al 32 1.74 (0.81)2.12 (1.05)7.15 (1.39)7.67 (1.14)
Colak et al 28 8 (8.5)7 (7.29)4 (4.25)1 (1)01 (1)01 (1)77 (81)73 (76)2.7 (6.2)1.9 (0.9)--
Deschamps et al 30 2.99 (2.26)0.39 (2.05)7.6 (5.4)7.9 (3.2)
Vretzakis et al 35 1 (1.33)1 (1.33)2 (2.66)2 (2.66)1 (1.33)01 (1.33)01 (1.33)1 (1.33)51 (68)63 (84)2.7 (3.8)2.7 (3.6)10.9 (3.6)10.2 (10.7)
Mohandas et al 33 02 (4)1.49 (0.38)1.7 (0.49)
Harilall et al 31
Slater et al 34 1 (0.8)1 (0.86)1 (0.8)01 (0.8)1 (0.86)
Murkin et al 10 01 (1%)1 (1%)3 (3%)1 (1%)4 (4%)001 (1%)1 (1%)8 (8)10 (10)1.25 (0.84)1.87 (2.67)6.1 (4.4)6.9 (5.5)
Summary effect estimate
RR (95% CI)
0.76
(0.30 to 1.96)
0.90
(0.43 to 1.89)
1.08
(0.40 to 2.91)
0.88
(0.52 to 1.49)
1.23
(0.46 to 3.32)
0.93
(0.77 to 1.12)
0.00
(−0.44 to 0.44)
−0.45
(−0.90 to 0.01)
  • AKI, acute kidney injury; ICU, intensive care unit; LOS, length of stay; MI, myocardial infarction; NIRS, near-infrared spectroscopy; RR, risk ratio.